From the Departments of Hepatobiliary Surgery.
Personnel, Dongyang People's Hospital, Dongyang, China.
Pancreas. 2021 Apr 1;50(4):571-578. doi: 10.1097/MPA.0000000000001798.
This study aimed to explore efficacy and safety between LAMSs (lumen-apposing metal stents) and DPPSs (double-pigtail plastic stents) in endoscopic ultrasound-guided drainage for pancreatic fluid collections.
Electronic databases were searched to identify relevant studies published until July 20, 2020.
Fifteen studies were identified in this study. Endoscopic ultrasound-guided drainage with LAMS has higher clinical success (90.01% vs 82.56%) (odds ratio [OR], 2.44; 95% confidence interval [CI], 1.79-3.33; P < 0.00001), less recurrence (OR, 0.44; 95% CI, 0.29-0.68; P = 0.0002), and fewer additional interventions (OR, 0.34; 95% CI, 0.211-0.55; P < 0.001). There was no significant difference between LAMS and DPPS in technical success (97.45% vs 97.38%) (OR, 0.92; 95% CI, 0.50-1.70; P = 0.80), adverse events (OR, 0.92; 95% CI, 0.41-2.09; P = 0.84), stent-related adverse events (OR, 0.78; 95% CI, 0.39-1.54; P = 0.47), and bleeding (OR, 1.47; 95% CI, 0.57-3.28; P = 0.42). Lumen-apposing metal stents have slightly more perforations (OR, 7.10; 95% CI, 1.22-41.30; P = 0.03) in studies of walled-off necrosis.
Lumen-apposing metal stents have the advantage of higher clinical success, less recurrence, and fewer additional interventions. However, LAMS may increase perforation for walled-off necrosis.
本研究旨在探讨内镜超声引导下引流胰腺液体积聚时, lumen-apposing 金属支架(LAMS)与双猪尾塑料支架(DPPS)的疗效和安全性。
检索电子数据库以确定截至 2020 年 7 月 20 日发表的相关研究。
本研究共纳入 15 项研究。LAMS 内镜超声引导下引流的临床成功率更高(90.01% vs 82.56%)(比值比[OR],2.44;95%置信区间[CI],1.79-3.33;P<0.00001),复发率更低(OR,0.44;95%CI,0.29-0.68;P=0.0002),且需要额外干预的次数更少(OR,0.34;95%CI,0.211-0.55;P<0.001)。LAMS 与 DPPS 在技术成功率(97.45% vs 97.38%)(OR,0.92;95%CI,0.50-1.70;P=0.80)、不良事件(OR,0.92;95%CI,0.41-2.09;P=0.84)、支架相关不良事件(OR,0.78;95%CI,0.39-1.54;P=0.47)和出血(OR,1.47;95%CI,0.57-3.28;P=0.42)方面无显著差异。在胰腺假性囊肿研究中,LAMS 穿孔的发生率略高(OR,7.10;95%CI,1.22-41.30;P=0.03)。
LAMS 具有更高的临床成功率、更低的复发率和更少的额外干预的优势。然而,LAMS 可能会增加胰腺假性囊肿的穿孔风险。